NCIt definition : Autologous peripheral blood lymphocytes (PBLs) transduced with an HLA class I histocompatibility
antigen A*11:01 (HLA-A1101)-restricted murine T-cell receptor (mTCR) that recognizes
the glycine to valine point mutation at position 12 (G12V) variant of K-RAS, with
potential antineoplastic activity. HLA-A1101 positive PBLs are harvested from a K-RAS
G12V-expressing cancer patient and transfected with a retroviral vector that encodes
anti-K-RAS G12V mTCR. The transduced PBLs are then expanded in culture. When reintroduced
to the patient, these anti-K-RAS G12V mTCR-expressing PBLs target and bind to K-RAS
G12V-overexpressing tumor cells, which results in both cytokine secretion and tumor
cell lysis. K-RAS, a member of the RAS family of oncogenes, serves an important role
in cell signaling, division and differentiation. Mutation of K-RAS may induce constitutive
signal transduction leading to tumor cell growth, proliferation, invasion, and metastasis.;